List view / Grid view
Abbott Laboratories is an American worldwide healthcare company. With headquarters in Lake Bluff, Illinois, it has 94,000 employees and operates in more than 150 countries.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion.
Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company’s in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test.
18 October 2013 | By Abbott
One in five Medicare patients is readmitted to a hospital each year at an estimated cost of $17.5 billion annually...
11 October 2013 | By Abbott
"Malnutrition in children is associated with poor health outcomes and this is especially important in the hospitalized child..."
4 September 2013 | By Abbott
Abbott announced promising preliminary results from a study presented at the ESC Congress 2013...
30 August 2013 | By Abbott
Analysis of more than 1 million adult hospital cases revealed 21 percent reduction in length of hospital stay and cost with nutritional intervention...
21 August 2013 | By kdm communications limited
Corresponding with the 60th Anniversary of the Association for Clinical Biochemistry, Abbott recently hosted an enthusiastically received session at the Annual ACB FOCUS National Meeting held in York, entitled The Diamond Generation; Pathology begins at 60...
21 August 2013 | By Abbott
Abbott has completed its acquisition of IDEV Technologies, a privately held company focused on developing next-generation medical devices...
19 August 2013 | By Abbott
Abbott has completed its acquisition of OptiMedica Corporation, a privately-held, Silicon Valley-based ophthalmic device company...
30 July 2013 | By Abbott
Abbott announced promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay...
29 July 2013 | By Abbott
As U.S. healthcare providers navigate a changing healthcare climate, clinical laboratories are playing an increasingly important role in helping them prevent medical errors, lower readmission rates, and improve patient care...
25 July 2013 | By Abbott
Abbott has received U.S. FDA clearance for its FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System™...
10 July 2013 | By Abbott
Enhanced deliverability with new stent delivery system...
20 June 2013 | By Abbott
Abbott has introduced the first FDA-approved HCV genotyping test...
11 June 2013 | By Abbott
Trial to study the innovative "dissolving" heart device...
4 June 2013 | By Abbott
Publication of positive outcomes...
3 June 2013 | By Abbott
New solution underscores Abbott’s continued commitment to ensuring the safety of the blood supply...
